Photo taken from Yakup Ergün/X
Jun 3, 2024, 12:44
Yakup Ergün: Adding LCT does not improve survival in oligometastatic NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X:
“NRG-LU002: maintenance systemic therapy vs local consolidative therapy plus maintenance therapy in oligometastatic NSCLC.
90% having received IO-based therapy.
Adding LCT does not improve survival. It increases side effects.
Presented by Dr. Puneeth Iyengar.”
Source: Yakup Ergün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29